全球耐药性问题和临床抗菌管道
1Center for Anti-Infective Agents, Vienna, Austria. utheuretzbacher@cefaia.com.
Nature reviews. Microbiology
|April 10, 2025
概括
目前的抗菌管道严重依赖于修改现有药物,对抗多药耐药病原体的成功有限. 为了更大的全球影响,需要新的策略和治疗方法,如菌体.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 临床抗菌管道显示了对新策略的有限关注,主要是修改现有的化学类来对抗耐药性.
- 现有的抗生素方法在全球范围内面临着不同的成功,这是由于不同的耐药性机制和条件,这影响了它们的社会价值.
- 虽然一些新型抗生素和辅助剂处于早期试验阶段,但仍需要取得重大突破.
研究的目的:
- 分析临床抗菌管道的当前状态.
- 确定现有的抗菌策略的局限性,并强调需要新的方法.
- 评估新兴疗法的潜力,如辅助剂和菌体.
主要方法:
- 对临床抗菌管道的全面分析.
- 审查当前的抗菌策略,耐药性机制和临床试验进展.
- 评估新型治疗方法,包括辅助剂和菌体.
主要成果:
- 管道中主要是对现有抗生素类的修改,对抗多药耐药病原体的成功有限.
- 抗生素的疗效在全球范围内因不同的耐药性模式和社会经济因素而有很大差异.
- 新型抗生素和辅助疗法有希望,但需要进一步开发和验证.
结论:
- 目前的抗菌药物开发策略不足以应对抗菌素耐药性日益增长的威胁.
- 新的目标,化学结构和治疗方法,包括菌体和抗病毒剂,对于未来的成功至关重要.
- 实现新抗菌方法的全部潜力需要解决可行性和全球社会影响.
相关概念视频
Antibiotic Selection
52.0K
Overview
52.0K
Defense Against Bacterial Pathogens
1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K
Bacterial Transformation
54.9K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
54.9K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Genomic DNA in Prokaryotes
43.2K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.2K
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K


